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Keloid is a dermal ﬁbroproliferative lesion of unknown etiology that commonly recurs after surgical excision. Post-
operative adjuvant electron beam (EB) irradiation has been successfully used to reduce keloid recurrences. To
provide new insights into the molecular mechanism behind the effect of EB irradiation, we used a cDNA microarray
screening of more than 5000 genes to assess early changes in gene expression between EB-irradiated and non-
irradiated keloid and non-lesional dermal ﬁbroblasts. Primary ﬁbroblast cultures from keloid and associated non-
lesional dermis obtained from ﬁve patients were exposed to 15 Gy EB irradiation and analyzed after 15 min
incubation. Early response to EB irradiation showed that 96 (1.8%) genes were modulated 2-fold or more in keloid
ﬁbroblasts. Upregulated genes accounted for 29.2% (28 genes), whereas downregulated genes comprised 70.8%
(68 genes), indicating a silencing of many genes in keloid ﬁbroblasts after EB irradiation. Many of the downreg-
ulated genes play roles in the enhancement of cell proliferation and extracellular matrix production, whereas
several of the upregulated genes involves in the promotion of apoptosis and extracellular matrix (ECM) degra-
dation. Using emerging bioinformatic tools and further corroboration, the interleukin 6 (IL-6) signaling pathway was
found to be mainly involved in EB irradiation response. We also showed co-expression of IL-6 and its specific
receptor (IL-6Ra) in keloid ﬁbroblasts that points to the existence of an IL-6 autocrine loop in these cells. These
results suggested that at the molecular level, EB irradiation might hinder keloid formation by regularizing dis-
turbances in the homeostatic equilibrium between inducer and inhibitor activities in the matrix system most likely
through the IL-6 pathway. Our study provides clues for the molecular mechanism(s) behind the beneﬁcial effect of
EB irradiation in reducing keloid recurrences and may help develop alternative strategies for the therapy and
prophylaxis of this lesion.
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Keloid is a fibroproliferative lesion characterized by exces-
sive collagen deposition. It develops as a result of abnormal
wound healing in susceptible individuals. Keloid is defined
as a scar within the skin that grows beyond the confines of
original wound. Many factors such as skin tension, wound
infection, racial difference, and genetic predisposition have
been implicated in the etiology of keloid lesion (Shiuh et al,
1996).
A number of treatment modalities have been employed
to overcome keloid or to relieve its symptoms. In general,
surgical excision alone has proved unsatisfactory because
of a recurrence rate of 45%–100% (Berman and Bieley, 1996).
This has led to the development of various adjuvant therapies
including radiotherapy (Berman and Bieley, 1996; Maarouf
et al, 2002; Ragoowansi et al, 2003). In a randomized trial for
keloid therapy, a combination of surgery and radiotherapy
appeared to be more effective (12.5% relapse) than that of
surgery and corticosteroid injections (33% relapse) at 12 mo
after treatment (Sclafani et al, 1996). Although keloid radi-
otherapy alone without surgery is an exception, early post-
operative electron beam (EB) irradiation has proved to be a
well-tolerated and effective method in reducing the recur-
rence rate down to 12%–28% (Lo et al, 1990; Mitsuhashi
and Miyashita, 1995; Maarouf et al, 2002; Ogawa et al,
2003). In general, EB irradiation appears to be preferable to
kilovoltage radiotherapy when treating keloids, since with
fast electrons, it is possible to achieve the most advanta-
geous dose distribution in tissue with least undesirable ef-
fects (Maarouf et al, 2002). The molecular mechanisms
underlying the effect of EB irradiation on keloid lesions,
however, remain elusive and a universal protocol for its ap-
plication has not yet been established. Tarott (1994) pro-
posed that the mode of action of irradiation in the treatment
A part of this study has been presented at the 32nd Meeting of
the Japanese Society for Wound Healing, Fukuoka, Japan (2002).
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of connective tissue hypertrophy is based on proliferation
inhibition and accelerated fibroblast differentiation.
Global gene expression analyses using cDNA microar-
rays have enabled the dissection of molecular events in the
irradiation response of tumor cells (Woong-Yang et al, 2002)
and normal tissue (Steven et al, 2002). On the other hand,
the availability of recently developed bioinformatic pro-
grams that automatically search the biological literature to
predict pathways of interacting genes has facilitated iden-
tification of gene regulatory networks (Yonan et al, 2003). In
this study, we used a cDNA microarray screening of more
than 5000 genes in keloid fibroblasts (KF) and non-lesional
dermal fibroblasts (NF) to identify genes involved in the early
response to EB irradiation. Early alterations in gene expres-
sion levels appear more likely to involve genes participating
in signaling pathways that determine the cell destiny. We
further applied the emerging bioinformatic tools to explore
what putative pathway(s) might be involved in EB irradiation
response.
Results
Effect of EB irradiation doses on KF We first examined
the response of KF to different doses of EB irradiation. The
KF responded to EB irradiation dose as a non-linear curve
and the cell death increased compared with the control,
reaching a peak at 10 Gy dose and slightly lower at 15 Gy
dose (Fig 1B). When the dose was increased to over 15 Gy
up to 30 Gy, no significant change was observed. Thus, a 15
Gy dose was chosen for the cDNA microarray analyses. In
addition, a comparable dose has been effectively used in
several clinical and experimental studies to prevent keloid
recurrences (Lo et al, 1990; Mitsuhashi and Miyashita, 1995;
Maarouf et al, 2002; Ogawa et al, 2003).
Gene expression analysis of KF and NF in response to
EB irradiation Comparison of gene expression profiles of
fibroblasts from the five keloid lesions showed comparable
levels of expression for all genes (none showed more than
1.5-fold variability). This was true for the five NF as well.
Thus, the variability among the cases was within an ac-
ceptable range. Comparison of gene expression profiles
between NF and KF revealed that many genes were mod-
ulated as depicted by scatter plots (Fig 1C, left panel ).
These modulations were considered to be related to the
keloid disease. Early response of KF to EB irradiation
showed modulations in a number of genes that were mostly
downregulated (Fig 1C, middle panel ). Further comparison
of gene expression profiles between EB-irradiated NF and
EB-irradiated KF revealed amelioration of most of the mod-
ulated genes that were seen in the absence of EB irradi-
ation, indicating a potential role for EB irradiation in
regularizing gene expression imbalances in KF (Fig 1C right
panel, see Fig 1C, left panel ). Early response of KF to EB
irradiation resulted in 96 ‘‘candidate-modulated genes’’ out
of the total of 5171 genes (1.8%; Table S1). Downregulated
genes accounted for 70.8% (68 clones), whereas 29.2% (28
clones) were upregulated. Of the 96 genes, 91 (95%) were
known genes, 65 (71.4%) being downregulated and 26
(28.6%) upregulated. The other five genes were EST, of which
three were downregulated and two were upregulated. Com-
Figure 1
(A) Model of retrieving candidate-mod-
ulated genes. Two groups of genes were
retrieved using the Vector Xpression 3.0
software: (1) Genes that were upregulated
in keloid fibroblasts (KF) compared with
non-lesional dermal fibroblasts (NF) and
became downregulated in KF after elec-
tron beam (EB) irradiation (KFþEB) and
(2) genes that were downregulated in KF
compared with NF and became upregu-
lated in KFþEB. Y-axis denotes the ex-
pression intensities. The two groups of
genes were then compiled together and
considered as the ‘‘candidate-modulated
genes’’ in response to EB irradiation. (B)
Effect of EB irradiation doses on KF. KF
(1  104) were cultured in 25 cm2 culture
flasks using Dulbecco’s modified Eagle’s
medium supplemented with 5% fetal bo-
vine serum for 24 h. The cells were ex-
posed to single doses of 0, 5, 10, 15, 20,
and 30 Gy EB irradiation. After a further 3
d culture in the same medium, the cells
were harvested using trypsin/EDTA,
washed in PBS, and fixed in 70% ethanol.
The cells were stained with propidium io-
dide (PI), and DNA fluorescence was
measured using a flow cytometer. The
percentages of cell death were deter-
mined and a corresponding curve was constructed. EB irradiation showed a stabilized effect at a more than 10 Gy dose. Data represent
mean  SD for three cases studied. (C) Scatter plots of cDNA microarray analyses. Left panel: Comparison of gene expression profiles between
NF and KF revealed that many genes were modulated. These modulations were attributed to the keloid disease. Middle panel: Early response of KF
to EB irradiation showed modulations in a number of genes that were mostly downregulated. Right panel: Further comparison of gene expression
profiles between EB-irradiated NF and EB-irradiated KF revealed amelioration of most of the modulated genes that were observed in the absence of
EB irradiation, indicating a possible role for EB irradiation in regularizing gene expression imbalances in KF (see left panel ).
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parison of gene expression profiles of NF and KF after EB
irradiation did not show specific difference in the response.
Validation of microarray data and veriﬁcation of down-
stream targets in interleukin (IL)-6 signal pathway The
validity of expression results of some of the genes was
confirmed by a semi-quantitative RT-PCR. In general, qual-
itative agreement between the cDNA microarray and RT-
PCR results was quite good, although there were differenc-
es in the quantitative extent of the gene expression alter-
ations between the two assay methodologies. This analysis
revealed that collagen type I alpha2 (COL1A2), fibronectin 1
(FN1), matrix metalloprotease 2 (MMP2), thymosin beta4
(TMSB4X), protease nexin 1 (PN1), and IL-6 genes were
downregulated in EB-irradiated keloid fibroblasts, in agree-
ment with the results obtained by the cDNA microarry anal-
ysis (Fig 2A). We further documented upregulation of a
selected gene of interest, PN1, at mRNA level in the five KF
cases as compared with their NF counterparts (Fig 2B). In
addition, since another gene of interest, IL-6, was down-
regulated, we sought to examine changes in mRNA ex-
pression of two downstream targets in the IL-6 signaling
pathway, namely STAT3 and ELK1 and found that these
genes were downregulated after EB irradiation (Fig 2C
and D).
Biological function and pathway analysis The biological
functions of the ‘‘candidate-modulated genes’’ were diverse
and included transcription factors, protein kinases and
phosphatases, cell cycle regulators, proteases, cytokines
and growth factors, extracellular matrix inducers and inhib-
itors, apoptotic and anti-apoptotic factors, as well as a
number of metabolic genes (Table S1).
To predict what putative pathways might be involved in
the response of KF to EB irradiation, a list of ‘‘candidate-
modulated genes’’ (n¼96) was loaded into the Pathway
Assist software. Of those genes, 91 were recognized by the
software and were thus subjected to subsequent analysis.
These genes consisted of genes related to cytokines and
growth factors, extracellular matrix synthesis, proteases
and inhibitors, apoptosis, and cell proliferation (Table S1). A
subset of functionally interrelated genes was identified and
a network of genes graphically represented (Fig 3). This
analysis predicted the involvement of IL-6 gene in the re-
sponse of KF to EB irradiation.
Quantiﬁcation of IL-6 secretion To determine whether
downregulation of IL-6 mRNA in EB-irradiated KF would
parallel its protein expression, we measured IL-6 secretion
in serum-free cultures of NF as well as non-irradiated and
EB-irradiated KF from the five cases by an ELISA method.
IL-6 secretion rates were 0.08  0.02 in NF, 0.52  0.04 in
non-irradiated KF, and 0.26  0.03 in EB-irradiated KF. IL-6
secretion was found to be significantly increased in KF ver-
sus NF (po0.01) or decreased in EB-irradiated KF com-
pared with non-irradiated KF (po0.05; Fig 4A).
Extracellular matrix (ECM) gene expression by addition
of IL-6 and EB irradiation or inhibition of IL-6 To confirm
that IL-6 signaling pathway is involved in EB irradiation
response on ECM gene expression, we examined if IL-6
addition in culture medium abolishes EB irradiation effect on
ECM gene expression or alternatively if inhibition of IL-6
could mimic EB irradiation effects on ECM gene expression.
We measured mRNA expressions of two principal ECM
molecules, COL1A2 and FN1, in KF after treatment with IL-6
peptide at various doses and EB irradiation or anti-IL-6 an-
tibody at various doses. The results showed that addition of
IL-6 in culture medium significantly and concentration-de-
pendently interfered with the suppressive effect of EB irra-
diation on COL1A2 and FN1 mRNA expressions (Fig 4B).
Furthermore, inhibition of IL-6 by anti-IL-6 antibody resulted
Figure 2
(A) Validation of microarray data by
semi-quantitative RT-PCR. Intensity val-
ues of mRNA expressions from the se-
lected genes normalized against the
intensity values of glyceraldehyde 3-
phosphate dehydrogenase mRNA con-
firm the downregulation of each gene af-
ter electron beam (EB) irradiation by
cDNA microarray analyses. (B) Upregu-
lation of protease nexin 1 (PN1) mRNA
in keloid fibroblasts (KF) versus non-
lesional dermal fibroblasts (NF). Semi-
quantitative RT-PCR showed increased
expression of PN1 mRNA in the five cas-
es of KF studied as compared with their
NF counterparts (po0.05). (C, D) Ver-
ification of downstream targets in
interleukin (IL)-6 signal pathway. Meas-
urements of STAT3 (C) and ELK1 (D)
mRNA expression in KF after EB irradia-
tion showed significant decreases.
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in concentration-dependent decreases in COL1A2 and FN1
mRNA expressions (Fig 4C).
Collagen synthesis on induction or inhibition of IL-6 To
provide evidence that IL-6 expression affects increased
collagen synthesis, we examined the effects of IL-6 induc-
tion or inhibition on collagen type I synthesis using various
doses of IL-1b peptide (a known IL-6 inducer) or anti-IL-6
antibody (as inhibitor). We measured procollagen I carboxy-
terminal propeptide (PICP) secreted by the KF that reflects
the synthesis of type I collagen. Addition of IL-1b peptide or
anti-IL-6 antibody in culture medium resulted in a concen-
tration-dependent increase or decrease in the synthesis of
collagen type I respectively (Fig 4D).
Immunoﬂuorescence and immunoperoxidase stainings
for IL-6 and its specific receptor (IL-6Ra) To assess the
effect of EB irradiation on the intensity of IL-6 protein ex-
pression in situ, we compared IL-6 expression between
non-irradiated and EB-irradiated KF by visual means using
immunofluorescence microscopy (Fig 5A–E). A considera-
bly weaker fluorescence intensity of IL-6 expression was
observed in EB-irradiated KF (Fig 5B) compared with their
non-irradiated counterpart (Fig 5A). In addition, the intensity
of IL-6 expression was greater in KF as compared with NF
(not shown).
To reveal whether KF co-expresses IL-6 and IL-6Ra, dual
immunofluorescence staining was performed (Fig 5C–E).
KF demonstrated co-localization of IL-6 and its specific re-
ceptor IL-6Ra.
To determine whether the in vitro increased IL-6 expres-
sion in KF reflected the in vivo expression, we assessed IL-6
expression by inmmunohistochemistry in frozen or paraffin
sections from 8 additional keloid lesions. KF showed strong
expression of IL-6 in 6 (75%), and weak or negative ex-
pression each in 1 case (Fig 5F). Fibroblasts immediately
surrounding the keloid area in the same cases showed no
reaction for IL-6. The six cases with strong IL-6 expression
also showed moderate to strong expression for IL-6Ra in KF
(Fig 5G). The other two cases had weak expressions. The
immunohistochemical data were thus corresponded to
those obtained from cultured cells.
Discussion
Despite extensive research, the nature of keloid lesion re-
mains unclear, yet its mode of therapy bears great clinical
importance, because of the frequent recurrences and lack
of standard treatment strategy. Cell culture experiments
have shown that different populations of fibroblasts may
exist in keloid patients and many studies have strongly
suggested heterogeneity in cell response of the fibroblasts
in the same individuals. In a previous study (Shiuh et al,
1996), about 25% of the fibroblasts cultured from keloid
Figure 3
Functional associations among candidate genes modulated in response to electron beam (EB) irradiation in keloid fibroblasts (KF). An
original graphical network represented by the Pathway Assist software predicts the involvement of interleukin-6 (IL-6) in response to EB irradiation in
KF. Squares marked with ‘‘þ ’’ or ‘‘’’ denotes positive or negative effect on the gene in the direction of arrows. The downregulation of IL-6 leads to
the downregulation of several genes that promote cell proliferation or extracellular matrix production or inhibit apoptosis in parallel with upregulation
of several genes that promote apoptosis or matrix degradation or inhibit cell proliferation.
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scar tissues were shown to have increased radiosensitivity
compared with those from the normal dermis of the same
patients. In contrast, other studies showed that both keloid
and normal fibroblasts were sensitive to X-ray irradiation,
and there was no significant difference between the two
groups (Kyu et al, 1994).
Although simple excision and closure result in a recur-
rence rate of more than 50%, several studies have shown
that surgery associated with post-operative EB irradiation
provide more than 70% success rate in prevention or re-
currence of keloids (Lo et al, 1990; Mitsuhashi and Miyas-
hita, 1995; Ogawa et al, 2003). The molecular mechanism(s)
behind the effect of EB irradiation has, however, not been
explored. To provide information on this aspect, we com-
pared gene expression profiles between non-irradiated and
EB-irradiated KF considering only those genes that were
initially found to be differentially expressed between KF and
paired NF from the same patients. Thus, we have analyzed
the genes most likely related to keloid disease. Since we
were able to compare two tissues from the same individual,
we avoided gene expression differences that might arise
because of genetic polymorphisms in different individuals.
Furthermore, we took advantage of the fact that cultures of
fibroblasts from keloid lesion maintain high levels of colla-
gen gene expression for several passages in culture. By
these analyses, we could identify several genes that were
modulated after EB irradiation (Table S1). Functionally,
these modulations included upregulation of several genes
that promote apoptosis or matrix degradation or inhibit cell
proliferation in parallel with the downregulation of several
others that promote cell proliferation or extracellular matrix
production or inhibit apoptosis.
Among the modulated genes, downregulation of SER-
PINE2 or PN1 in KF after EB irradiation attracted our at-
tention. This gene was first discovered and characterized as
a serpin-class inhibitor of thrombin released from foreskin
fibroblasts (Baker et al, 1980). Its main targets are the pro-
teases, including thrombin, urinary plasminogen activator
(uPA), and plasmin (Scott et al, 1985). It has also activity
toward trypsin and urokinase, and binds heparin. Thus, the
physiological target of PN1 may include several mediators
of matrix metabolism. PN1 binds, possibly by a heparin-like
molecule, to the outer surface of cells or to the extracellular
matrix and may protect cells and matrix proteins against
proteolytic degradation. In our study, downregulation of
PN1 in KF after EB irradiation might result in deterioration of
matrix metabolism and promotion of matrix degradation.
We further documented that PN1 mRNA was aberrantly
upregulated in KF compared with NF (Fig 2B). In addition,
after EB irradiation, other genes including plasminogen
activator inhibitor, type 1, member 1 (PAI-1 or SERPINE1),
tissue palsminogen activator (PLAT), and urokinase plasm-
inogen activator (PLAU) were also downregulated. In light of
the growing evidence that the plasminogen activator and
inhibitor system play an essential role in regulating extra-
cellular matrix metabolism in keloid lesions, our results
Figure 4
(A, B) Electron beam (EB) irradiation effects on interleukin (IL)-6 and extracellular matrix (ECM) components. Enzyme immunoassay detection
of interleukin 6 (IL-6) secretion by non-lesional dermal fibroblasts (NF), keloid fibroblasts (KF), and EB-irradiated KF in the five cases revealed a
significantly increased secretion by KF that was decreased after EB irradiation (A). EB irradiation effects on ECM components collagen type I alpha2
(COL1A2) and fibronectin 1 (FN1) mRNA expressions after addition of IL-6 peptide showed a significantly and concentration-dependently increase in
the mRNA expressions. Inhibition of IL-6 by anti-IL-6 antibody showed a concentration-dependent decrease in COL1A2 or FN1 mRNA expression
(C). (C, D) Effects of IL-6 on ECM components. Radioimmunoassay detection of procollagen I carboxyterminal propeptides (PICP) in KF after
induction (by IL-1b) or inhibition (by anti-IL-6 antibody) of IL-6 revealed a concentration-dependent increase or decease in the synthesis of collagen
type I, respectively ( and  indicate po0.05 and po0.01, respectively).
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suggest that this system is most likely to be affected by EB
irradiation.
To determine what molecular mechanisms might be in-
volved in the effect of EB irradiation in KF, we sought to
apply emerging bioinformatic tools to identify putative gene
regulatory interactions between the selected set of differ-
entially expressed genes in KF after EB irradiation. The re-
sulting network of functionally related genes predicted that
IL-6, an inflammatory cytokine, may play a pivotal role in
modulating response to EB irradiation (Fig 3). Previous
studies reported that cytokines could alter fibroblast prolif-
eration, synthesis of extracellular matrix components, as
well as other functions that might regulate pathogenesis of
autoimmune fibrotic diseases (Elias et al, 1990; Ferrarini
et al, 1990). It was also found that IL-6 produced by fib-
roblasts may be involved in the pathogenesis of fibrosis
associated with rheumatoid arthritis, progressive scleroder-
ma, and pulmonary interstitial fibrosis (Tan et al, 1990; Fe-
ghali et al, 1994; Gurram et al, 1994; Shahar et al, 1996). In
scleroderma and pulmonary fibrosis, overproduction of IL-6
has been linked to the development of fibrosis (Feghali et al,
1992; Shahar et al, 1996). IL-6 was shown to induce the
proliferation of fibroblasts as well (Mihara et al, 1995). More
recently, increased IL-6 gene expression and overproduc-
tion of IL-6 by KF has been reported, suggesting an altered
increased autocrine regulation of IL-6 by KF that signifies a
central role for this cytokine in the pathogenesis of keloid
lesions (Xue et al, 2000). In pulmonary fibrosis, contrary to
the traditional concept that cytokine secretion by epithelial
and inflammatory cells induces parenchymal lung fibro-
blasts to overproduce collagen, several studies indicate that
the pluripotential bone-marrow-derived cells can engraft
into lung tissue and produce collagen (Prockop, 1997; Abe
et al, 2001). Furthermore, a recent study in a mouse model
of pulmonary fibrosis provided evidence that most of the
collagen-producing fibroblasts in the fibrotic foci in the lung
were of bone marrow rather than of local origin (Hashimoto
et al, 2004). These cells may be recruited to the lung by
chemokines secreted from macrophages. Since keloid scar
develops after wound healing and several cytokines and
chemokines including IL-6 are involved in this process, it is
intriguing to speculate that these substances may be re-
sponsible for recruiting fibroblast precursors from the bone
marrow into the site of wound healing to represent patho-
logic collagen-producing fibroblasts and overproduce col-
lagen in this disease.
The downregulation of IL-6 gene after EB irradiation in
our study appears to have conferred a beneficial effect to-
ward hindering keloid formation. In IL-6 signal transduction
pathway (Fig 6), IL-6 binds to its specific receptor IL-6Ra
and initiates cellular events, that include activation of JAK
kinases and Ras-mediated signaling. Consequently, JAK
kinases phosphorylate and activate STAT transcription fac-
tors, especially STAT3, that move into the nucleus and ac-
tivate transcription of genes containing STAT3 response
elements. The Ras-mediated signaling through Shc, GRB2
and Sos-1 upstream, and RAF1 and activating MAP kinases
downstream activates transcription factors such as ELK-1
and NF-IL-6 (CEBPB). These factors and others such as AP-
1 and serum response factor (SRF) that respond to many
different signaling pathways regulate a variety of complex
promoters and enhancers that respond to IL-6 and other
signaling factors. Accordingly, the downregulation of IL-6 by
EB irradiation would result in attenuation of these processes,
Figure 5
(A–E) Immunofluorescence staining for
interleukin 6 (IL-6) and its receptor IL-
6Ra. Considerably weaker fluorescence
intensity of IL-6 expression was observed
in electron beam (EB)-irradiated keloid
fibroblasts (KF) (B) compared with their
non-irradiated counterpart (A). In addition,
a marked increased intensity of IL-6 ex-
pression was found in KF compared with
non-lesional dermal fibroblasts (NF) (not
shown). Dual immunofluorescence stain-
ings showed that IL-6 (C) and its receptor
IL-6Ra (D) were co-expressed (E) in keloid
fibroblasts. (F, G) Immunoperoxidase
staining for IL-6 and its receptor IL-
6R-a. Immunohistochemical stainings for
IL-6 and its receptor (IL-6Ra) in compa-
rable areas from serial parrafin sections of
a keloid lesion showed moderate to
strong staining for IL-6 (F) and its recep-
tor (G) in the KF as opposed to negative
reaction in fibroblasts immediately sur-
rounding the keloid area (asterisks). In-
sets: higher magnifications of the squared
areas. Scale bars¼50 mm.
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leading to the decreased transcription of several genes
including those related to the cell proliferation and matrix
synthesis. Furthermore, we confirmed downregulation of
two downstream targets in the IL-6 signal pathway, namely
STAT3 and ELK1 in KF after EB irradiation, which adds
support to this hypothesis.
In our study, the key elements of the IL-6 signaling path-
way, IL-6 and its receptor IL-6Ra were co-expressed in KF
that strongly implied an autocrine role for IL-6 in KF. These
results were supported by a previous study that also sug-
gested an altered increased autocrine regulation of IL-6 by
KF (Xue et al, 2000), and further signifies a central role for IL-
6 cytokine in the pathogenesis of keloid lesions. In addition,
it is likely that the EB irradiation might inhibit increased au-
tocrine regulation of IL-6 by KF. Generally, cytokines other
than IL-6 play a role in the regulatory secretion of IL-6
through their interaction with keratinocytes, T cells, and the
extracellular matrix. Autocrine regulation of IL-6 is affected
by IL-6 itself and other pro-inflammatory factors (Maruyama
et al, 1995; Boxman et al, 1996; Sporri et al, 1996). Some
studies have shown that interferon (IFN)-g regulates IL-6
secretion from fibroblasts by stimulating the expression of
MHC class II and CD40 (Mourad et al, 1992; Yellin et al,
1995). IFN-g has been reported to increase protein produc-
tion, inhibit DNA synthesis, and increase IL-6 expression in
normal dermal fibroblasts (Maruyama et al, 1995). On the
other hand, ionizing irradiation was found to reduce the IFN-
g mRNA expression (Han et al, 2002). Low-dose irradiation,
however, is known to exert an anti-inflammatory effect
(Roedel et al, 2002) and has been shown to induce IFN-g
expression (Shen et al, 1991). In fact, low-dose radiotherapy
has been effectively used in the treatment of a wide variety
of benign conditions. Collectively, the downregulation of IL-
6 in response to EB irradiation might be also via the IFN-g
system.
In this study, we used low-passage primary fibroblast
cultures to obtain results as close as to the in vivo tissue
condition. It should be noted that gene expression profiles
can be vastly different between the cells in long-term es-
tablished cultures in vitro and whole tissue in vivo. Further-
more, the cell-cell, cell-ECM, and cell-host interactions may
significantly affect gene expression profile in vivo relative to
the in vitro conditions of established cell lines. These pos-
sibilities may also apply when considering if the effects seen
with 15 Gy irradiation in vivo are reflected when using the
same dose in irradiating monolayer cultures of fibroblasts
in vitro. Fibroblast heterogeneity has been well documented
with respect to a variety of functions such as proliferation
rate, collagen synthesis, and cytokine production. Pheno-
typic diversity and differences in morphology and cell size
within fibroblast populations also exist. One limitation of our
study may be attributed to lack of identification of different
subsets of fibroblasts, and variations in the behavior of
fibroblasts in vitro relative to the in vivo environments. In
addition, it has been shown that keratinocytes may play
an important role in the pathogenesis of keloid (Funayama
et al, 2003). KF co-cultured with keloid keratinocytes
were significantly more proliferative and resistant to
apoptosis than those co-cultured with normal keratin-
ocytes, suggesting that keloid keratinocytes may contri-
bute to the keloid formation. In our study, comparison of
gene expression profiles of NF and KF after EB irradiation
did not show specific difference in the response. Taken to-
gether, these findings suggest that the possible benefits of
EB irradiation in vivo may not be limited to the altered ex-
pression of genes in KF cultures and may include changes
in keratinocytes and other lesional cell types. Nevertheless,
our study identified several putative target genes that can
be further investigated in relation to the pathogenesis of
keloid lesion.
In conclusion, our differential gene expression and path-
way analyses of KF in response to EB irradiation revealed
that the inflammatory cytokine IL-6 may play a central role.
The involvement of IL-6 was confirmed by the effects shown
on ECM gene expression and collagen synthesis in KF
through the induction or inhibition of IL-6 expression. We
also showed the coexpression of IL-6 and its specific re-
ceptor IL-6Ra in KF that points to the existence of an IL-6
autocrine loop in KF. These findings could provide clues for
the molecular mechanism(s) behind the beneficial effect of
EB irradiation in reducing keloid recurrences and may have
implication in other conditions in which fibroblasts produce
constitutively increased amounts of IL-6.
Materials and Methods
Tissue specimens Tissue samples from lesional areas of keloid
along with associated non-lesional skin borders (2–4 mm periph-
eral rim) were obtained from five patients with untreated primary
keloids during surgery. Informed consents were obtained from all
patients. In addition, this study was approved by the Institutional
Review Board of the Nippon Medical School and was conducted
according to Declaration of Helsinki Principles. All patients were
females and ranged in age from 23 to 28 y. All keloid lesions were
located on the chest area and had developed after healing of acne
vulgaris. There was no sign of acne activity and no patient was
under any form of therapy at the time of obtaining tissue samples.
Figure 6
Interleukin 6 (IL-6) signal transduction pathway. Downregulation of
IL-6 by electron beam irradiation would result in attenuation of the
downstream target genes, leading to the decreased transcription of
several genes including those related to the cell proliferation and matrix
synthesis.
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Hematoxylin- and eosin-stained sections from the tissues were
histologically examined to confirm keloid and associated non-les-
ional skin features. There was no evidence of recurrence during a
follow up period of 3 y after post-operative EB irradiation.
Cell culture and effect of EB irradiation doses on KF Primary
fibroblast cultures were established as previously described
(Arakawa et al, 1990). Fibroblasts from KFand NF were cultured
in Dulbecco’s modified Eagle’s medium (DMEM), supplemented
with 10% fetal calf serum, penicillin (100 IU per mL), streptomycin
(100 mg per mL), and amphotericin B (0.25 mg per mL) at 371C in a
humidified 5% CO2 incubator. The cells were harvested by try-
psinization (0.25%) and secondary cultures were maintained in the
same medium until reaching 80% confluence. Only low-passage
cultures (passage 3–4) were utilized in this study.
To assess the effect of EB irradiation doses on KF, 1  104 KF
were cultured in 25 cm2 culture flasks using DMEM supplemented
with 5% fetal bovine serum for 24 h. The cells were exposed to
single doses of 0, 5, 10, 15, 20, and 30 Gy EB irradiation. After a
further 3 d culture, the cells were harvested using trypsin/EDTA,
washed in PBS, and fixed in 70% ethanol. The cells were stained
with propidium iodide (PI), and DNA fluorescence was measured
using a flow cytometer according to a method described previ-
ously (Nicoletti et al, 1991). The percentages of cell death were
determined and a corresponding graph was constructed.
Irradiation and RNA preparation A linear accelerator machine
(Mitsubishi Electric Linac EXL-6SP, Tokyo, Japan) capable of gen-
erating monoenergicEB at 6 MeV was used. This equipment en-
ables irradiation of the skin to a depth of 0.5–1.5 cm. In addition,
the length of the irradiation field is not limited. Since EB has the
depth dose characteristic, all deeper structures are spared. Before
irradiation, the culture medium was exchanged with fresh medium.
The flasks (75 cm2) containing nearly 80% confluent cells were
transferred to the radiology department and each flask received
irradiation with a calibrated dose of 15 Gy with a 6.0 MeV EB. The
control flasks received only a medium exchange without EB irra-
diation. After 15 min incubation, fibroblasts from EB-irradiated and
non-irradiated flasks were harvested and subjected to RNA isola-
tion using the RNeasy Midi Kit (QIAGEN, Hilden, Germany) based
on the manufacturer’s instruction. The RNA was treated with DNa-
se and precipitated using 95% ethanol prior to cDNA synthesis.
Isolated RNA was electrophoresed through 1.0% agarose–formal-
dehyde gels to verify the quality of the RNA, and RNA concentra-
tions were determined by UV spectrophotometry.
Microarrays and hybridization The cDNA microarray filters
(DermArray, ID 1001) were hybridized according to a protocol
developed by the manufacturer (Invitrogen/ResGen, Huntsville,
Alabama; http://www.resgen.com). Total RNA (1 mg) was utilized
as template for a reverse transcriptase reaction (Superscript II,
Invitrogen) to create [33P]dCTP labeled cDNA probes. Reactions
were purified by chromatography columns (Bio-Spin 6, Bio-Rad
Labs, Hercules, California). The filters were pre-washed in boiling
0.5% SDS for 5 min, placed individually in hybridization roller bot-
tles with 5 mL MicroHyb solution (Invitrogen/ResGen), pre-hybrid-
ized with 5 mg denatured poly-dA and Cot-1 DNA (Invitrogen/
ResGen) for 2 h at 421C, and then hybridized overnight with in-
dividual [33P]-labeled cDNA probes. The filters were washed for
20 min in hybridization bottles at 501C each with 2  SCC for three
times, 1% SDS for two times, and 0.5  SCC/1% SDS for one
time. Moist filters were wrapped individually with plastic wrap,
carefully oriented and exposed to phosphor-storage screens (BAS
cassette 2040, Fujifilm, Tokyo, Japan) for 3 h. Exposed screens
were imaged (Molecular Imager FX, Bio-Rad) and tiff files imported
into Pathways 4.0 software (Invitrogen/ResGen) for image align-
ment, translation of the raw hybridization intensities, and compar-
ative analyses. For each gene, a ratio was generated by dividing
the normalized expression intensity in EB-irradiated fibroblasts by
the normalized intensity of the same gene in non-irradiated coun-
terpart fibroblasts. Genes whose expression changed greater than
2-fold (up or down) in each comparison pair were considered to be
differentially expressed. The experiments were conducted inde-
pendently for two to three times on different filters. For each gene,
the ratios for the five cases of KF or NF were averaged.
Analysis of microarrays We first determined the gene expression
intensity profiles of: (1) NF, (2) KF, and (3) EB-irradiated KF (KFþEB).
After normalization of the data, the expression profile of NF was
compared with that of KF and two groups of upregulated and
downregulated genes were extracted. These were considered as
keloid disease-related genes. Similarly, the expression profile of KF
was compared with that of KFþEB and two groups of upregulated
and downregulated genes were extracted. These were considered
as EB irradiation-related genes. The resultant four groups of mod-
ulated genes with greater than 2-fold changes in normalized in-
tensities were exported to Excel files and analyzed using the Vector
Xpression 3.0 software (World Fusion, Tokyo, Japan) for compre-
hensive gene expression analysis. The ratio of each of the up-
regulated or downregulated keloid disease-related genes was
compared to the ratio of the same gene (when present) from the list
of EB irradiation related genes and two groups of genes were ul-
timately retrieved (Fig 1A) and recorded as: (1) genes that were
upregulated in KF compared with NF and became downregulated
in KFþEB and (2) genes that were downregulated in KF compared
with NF and became upregulated in KFþEB. The A and B groups
of genes were compiled together and considered as the ‘‘candi-
date-modulated genes’’ in response to EB irradiation. These mod-
ulated genes were also examined by cluster analysis, to assign
hierarchical grouping to genes whose expression similarly varied
(Eisen et al, 1998).
Semi-quantitative RT-PCR Some of the cDNA microarray results
were verified by a semi-quantitative RT-PCR. Selection of genes
was limited to the most frequently represented genes (those with a
‘‘present call’’ in at least four of five keloid cases). RNA samples
from the same stocks were used for the cDNA microarray and RT-
PCR analyses. From each sample, 1.5 mg of total RNA was re-
verse-transcribed using the gene-specific primers. The number of
PCR cycles was optimized in each case to ensure that product
intensity fell within the linear phase of amplification. The primer pair
sequences were: COL1A2 forward 50-ATTAACTCCTTCCCCCGTTC-
30 (nucleotides 149–168), reverse 50-TGGCAAAGAACAAATGCTGA-30
(nucleotides 663–644); FN1 forward 50-CGGAAAAGGAGAATTA-
AGTG-30(nucleotides 5–25), reverse 50-GCCTTCCAAAGAAACGA-
TT G-30 (nucleotides 332–313); MMP2 forward 50-TGGG-CAACAAA
TATGA GAGCTG-30 (nucleotides 1356–1377), reverse 50-CGGC-
ATCCAGGTTATCGGG-G-30 (nucleotides 2128–2147); TMSB4X
forward 50-GCCTTCCAAAGAAACGATTG-30(nucleotides 64–83),
reverse 50-ATTACAGCCTGCAGGACACC-30 (nucleotides 565–543);
PN1 forward 50-GGTCCTCGTCAACGCAGTGTA-30 (nucleotides
777–796), reverse 50-TGGCAGACAGCG GAGTGG-30 (nucleotides
1292–1273);IL-6 forward 50-ACAGCCACTCACCTCT TCAG-30
(nucleotides 194–213), reverse 50-CCATCTTTTTCAGCCATCT TT-
30 (nucleotides 341–361). In addition, mRNA expressions of two
downstream targets in the IL-6 signal pathway, STAT3 forward 50-
AAGGACATCAGTGGCAAG-30 (nucleotides 1876–1894), reverse
50-ACAGGCGGACAGAACA TAG-30 (nucleotides 2572–2591), and
ELK1 forward 50-GACACGACTCTGCCATCCAT-30 (nucleotides
2250–2270), reverse 50-AGGAGGCTTGGGGTCAGAGG-30 (nucleo-
tides 3092–3112), were examined. The expected PCR products
were 515, 328, 792, 500, 516, 168, 715, and 717 bp for COL1A2,
FN1, MMP2, TMSB4X, PN1, IL6, STAT3 and ELK1, genes, respec-
tively. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
used as the internal control. The PCR bands were quantitated by
densitometry and expressed relative to GAPDH.
Biological function and pathway analysis Gene functions were
obtained from the Gene Cards database (http://bioinformatics.
weizmann.ac.il/cards/). In addition, we used a recently available
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Pathway Assist software (Strategene, La Jolla, California) that
allows the user to explore gene interaction networks represented
in the ResNet database (a comprehensive database of molecular
networks compiled by proprietary natural-language-processing
techniques applied to the whole PubMed database) (Yonan et al,
2003). We explored functional interrelationships among the genes
defined as ‘‘candidate-modulated genes’’ in response to EB irra-
diation in KF. The structural design of ResNet and Pathway Assist
has been described elsewhere (http://www.ariadnegenomics.
com). The program allows the user to query the database and
construct specific networks relative to genes of interest. The list of
‘‘candidate-modulated genes’’ was loaded into the Pathway Assist.
The ‘‘Build Pathway’’ function was used to search for pathways
beginning with these genes. The functional relationships were then
graphically represented by the software as a network.
ELISA of IL-6 One hundred microliters of a 7  104 cells per mL
suspension in DMEM with 5% FBS was seeded in 96-well plates in
triplicate for 3 d. Then, 100 mL of serum-free medium was added
for 12 h. The supernatants were collected for detection of IL-6
using the human IL-6 immunoassay according to the manufactur-
er’s instructions (R&D Systems, Minneapolis, Minnesota). Briefly,
the samples were incubated in plates coated with anti-IL-6 anti-
body for 2 h at room temperature. The plates were then incubated
with the antibody against IL-6 conjugated to horseradish per-
oxidase for 2 h at room temperature. Finally, substrate solution was
added to each plate for chromogenic reaction. All plates were read
using an ELISA reader set at 450 nm. Each assay was performed in
triplicate and the results are presented as means  SEM.
ECM gene expression by addition of IL-6 and EB irradiation or
inhibition of IL-6 KF was seeded on 24-well plates at 7  104 cell
per well. After reaching subconfluence, the cultures were serum
deprived for 24 h. IL-6 peptide (Sigma-Alderich, St Louis, Missouri)
was added to a group of cultures at doses 0, 10, 20, and 40 ng per
mL of serum-free medium and the cultures were incubated for an
additional 12 h and then subjected to 15 Gy EB irradiation. After 15
min incubation, the cells were collected. Anti-IL-6 monoclonal an-
tibody was added to another group of cultures at doses between 0,
10, 20, and 40 mg per mL of serum-free medium and the cultures
were incubated for an additional 12 h acnd then the cells were
collected. The collected cells from both groups were examined for
COL1A2 and FN1 mRNA expressions by RT-PCR. The PCR bands
were quantitated by densitometry and expressed relative to GAP-
DH. The results were presented as mean  SEM of three inde-
pendent experiments.
Quantiﬁcation of PICP on induction or inhibition of IL-6 Col-
lagen type I derives from a larger protein termed procollagen type I,
which has propeptide extensions at both ends of the molecule.
Before the collagen molecules are assembled into fibers, the pro-
peptides are removed by specific enzymes. The sequence re-
moved from the carboxyterminal, end namely PICP, is secreted by
the cells and its measurement reflects the synthesis of type I col-
lagen. KF was seeded on 24-well plates at 7  104 cell per well.
After reaching subconfluence, the cultures were serum deprived
for 24 h. IL-1b (Sigma-Aldrich), a known inducer of IL-6, or anti-IL-6
monoclonal antibody was then added at doses between 10 and 40
ng per mL or 10–40 mg per mL serum-free medium, respectively.
The cultures were incubated for an additional 24 h. The medium in
each well was collected and processed for PICP radioimmunoas-
say (RIA) using rabbit anti-human PICP antibody (Orion Diagnos-
tica, Espoo, Finland). The results were expressed as mean  SEM
of three independent experiments.
Immunoﬂuorescence and immunoperoxidase stainings An in-
direct immunofluorescence method was applied to the primary
cultures of KF and their NF counterparts. Cells were seeded in
chamber slides (Nalge Nunc International, Naperville, Illinois) at
2.5  104 cells per chamber and cultured overnight. Two sets of
chamber slides from each sample were prepared, of which one
received 15 Gy EB irradiation. After a further 18 h culture, the cells
were fixed in cold acetone, washed with PBS, and reacted with
10% normal horse serum for 30 min to inhibit non-specifc binding
sites. The cells were incubated overnight with 1:50 dilution of a
monoclonal anti-human IL-6 followed by washes in PBS and re-
action with 1:100 dilution of a FITC-conjugated horse anti-mouse
IgG (Vector Labs, Burlingame, California). Dual immunofluores-
cence staining was also performed to assess co-localization of IL-
6 and IL-6Ra. Here, the cells were incubated overnight with a
mixture of 1:50 dilution of a monoclonal anti-human IL-6 and 1:100
dilution of a polyclonal rabbit anti-human IL-6Ra (Santa Cruz Bio-
technology, Santa Cruz, California) followed by washes with PBS
and incubation with a mixture of 1:100 dilutions of FITC-conjugated
horse anti-mouse IgG and Texas-red conjugated goat anti-rabbit
IgG (Vector Labs) for 30 min. The reactions were examined using
an immunofluorescence microscope.
Immunoperoxidase staining for IL-6 and IL-6Ra was performed
on frozen or deparaffinized paraffin sections from 8 additional
keloid lesions with location on chest area using a streptavidin–
biotin–peroxidase complex method (Niyazi et al, 2003). Briefly, en-
dogenous peroxidase in tissues was blocked with 0.3% hydrogen
peroxide for 30 min. After washes with PBS, non-specific binding
sites in tissues were blocked with 10% normal goat serum and the
sections were incubated overnight with 1:50 dilution of monoclonal
anti-human IL-6 or ployclonal rabbit anti-human IL-6R-a antibody.
After washes with PBS, biotinylated goat anti-mouse or anti-rabbit
IgGs was appplied followed by washing and detection using
a streptavidin–biotin–peroxidase staining kit (Histofine, Nichirei,
Japan). Diaminobenzidine was used as chromogen. The sec-
tions were counterstained with hematoxylin. Negative controls
for immunofluorescence and immunoperoxidase methods included
ommision of the primary antibody and its substitution with non-
immune rabbit serum.
Statistical analysis Statistical analyses were performed using the
Student’s t test for paired data to identify differences within groups
before and after a given treatment and Bonferroni’s test to identify
differences between groups. A p value of less than 0.05 was con-
sidered as significant.
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